In contrast, in BRCA, ISG15 enhances STAT1/2 activity through UBA7-mediated ISGylation, thereby increasing the expression of chemokines such as CXCL9/10/11 [54]. The gene discussed is ISG15; the disease is invasive breast carcinoma.